367 related articles for article (PubMed ID: 19698809)
1. Decision support in vaccination policies.
Piso B; Wild C
Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
[TBL] [Abstract][Full Text] [Related]
2. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
3. Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.
Kimman TG; Boot HJ; Berbers GA; Vermeer-de Bondt PE; Ardine de Wit G; de Melker HE
Vaccine; 2006 May; 24(22):4769-78. PubMed ID: 16616803
[TBL] [Abstract][Full Text] [Related]
4. An analytical framework for immunization programs in Canada.
Erickson LJ; De Wals P; Farand L
Vaccine; 2005 Mar; 23(19):2470-6. PubMed ID: 15752833
[TBL] [Abstract][Full Text] [Related]
5. Criteria for inclusion of vaccinations in public programmes.
Houweling H; Verweij M; Ruitenberg EJ;
Vaccine; 2010 Apr; 28(17):2924-31. PubMed ID: 20189486
[TBL] [Abstract][Full Text] [Related]
6. Translational research to assist policy decisions about introducing new vaccines in developing countries.
Clemens JD; Jodar L
J Health Popul Nutr; 2004 Sep; 22(3):223-31. PubMed ID: 15609774
[TBL] [Abstract][Full Text] [Related]
7. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
8. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
[TBL] [Abstract][Full Text] [Related]
9. The decision making process on new vaccines introduction in South Africa.
Ngcobo NJ; Cameron NA
Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
[TBL] [Abstract][Full Text] [Related]
10. The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.
Senouci K; Blau J; Nyambat B; Coumba Faye P; Gautier L; Da Silva A; Favorov MO; Clemens JD; Stoeckel P; Gessner BD
Vaccine; 2010 Apr; 28 Suppl 1():A26-30. PubMed ID: 20412992
[TBL] [Abstract][Full Text] [Related]
11. Conceptual frameworks and key dimensions to support coverage decisions for vaccines.
González-Lorenzo M; Piatti A; Coppola L; Gramegna M; Demicheli V; Melegaro A; Tirani M; Parmelli E; Auxilia F; Moja L;
Vaccine; 2015 Feb; 33(9):1206-17. PubMed ID: 25533328
[TBL] [Abstract][Full Text] [Related]
12. Comparison of NITAG policies and working processes in selected developed countries.
Ricciardi GW; Toumi M; Weil-Olivier C; Ruitenberg EJ; Dankó D; Duru G; Picazo J; Zöllner Y; Poland G; Drummond M
Vaccine; 2015 Jan; 33(1):3-11. PubMed ID: 25258100
[TBL] [Abstract][Full Text] [Related]
13. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
Mahoney R
J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
[TBL] [Abstract][Full Text] [Related]
14. The importance of engaging policy-makers at the outset to guide research on and introduction of vaccines: the use of policy-maker surveys.
DeRoeck D
J Health Popul Nutr; 2004 Sep; 22(3):322-30. PubMed ID: 15609785
[TBL] [Abstract][Full Text] [Related]
15. [Ethical analysis of the decision-making process in occupational health practice].
Franco G
Med Lav; 2005; 96(5):375-82. PubMed ID: 16711638
[TBL] [Abstract][Full Text] [Related]
16. Setting priorities for new vaccination programs by using public health officers and immunization managers opinions.
Gilca V; Sauvageau C; McNeil S; Gemmill IM; Dionne M; Dobson S; Ouakki M; Lavoie F; Duval B
Vaccine; 2008 Aug; 26(33):4204-9. PubMed ID: 18582998
[TBL] [Abstract][Full Text] [Related]
17. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
Jeuland M; Whittington D
Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
[TBL] [Abstract][Full Text] [Related]
18. [Basis for vaccine recommendations].
Lévy-Bruhl D
Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
[TBL] [Abstract][Full Text] [Related]
19. Population access to rotavirus vaccination in industrialized countries: lessons learnt from current experience.
Weil-Olivier C; Millier A; Toumi M; Trichard M
Expert Rev Vaccines; 2014 Nov; 13(11):1405-17. PubMed ID: 25142637
[TBL] [Abstract][Full Text] [Related]
20. Population access to new vaccines in European countries.
Blank PR; Schwenkglenks M; Sardos CS; Patris J; Szucs TD
Vaccine; 2013 Jun; 31(27):2862-7. PubMed ID: 23632307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
